Cytotoxic functions and susceptibility to apoptosis of human CD56bright NK cells differentiated in vitro from CD34+hematopoietic progenitors

被引:13
|
作者
Zamai, Loris [1 ,2 ]
Del Zotto, Genny [1 ]
Buccella, Flavia [1 ]
Galeotti, Laura [1 ]
Canonico, Barbara [1 ]
Luchetti, Francesca [1 ]
Papa, Stefano [1 ]
机构
[1] Univ Urbino Carlo Bo, Dept Earth Life & Environm Sci, I-61029 Urbino, Italy
[2] INFN Gran Sasso Natl Lab, Laquila, Italy
关键词
NK cells; cell differentiation; cytotoxicity; cellular activation; apoptosis; NATURAL-KILLER-CELLS; ACTIVATING RECEPTORS; LIGAND TRAIL; PRECURSORS; EXPRESSION; MATURATION; IMMATURE; SUBSET; ACQUISITION; INDUCTION;
D O I
10.1002/cyto.a.22025
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cytotoxic functions and susceptibility to apoptosis are crucial aspects of NK cells suitable to counter cancer after infusion in oncologic patients. To test the feasibility and the usefulness of infusing in vitro generated NK cells, these two features were investigated in NK cells developed in vitro from CD34+ hematopoietic progenitors. Purified CD34+ cells were cultured for 1530 days with FLT-3 ligand (FLT3-L) and IL-15 with or without IL-21. To induce terminal differentiation, NK cells were cultured for further 15 days with IL-15, IL-21, or their combination. A CD56dim/CD16+ NK subset, expressing high level of perforin, granzymes, and LFA-1, appeared early in cultures with FLT3-L, IL-15, and IL-21, but it quickly died, indicating its predisposition to apoptosis. On the contrary, CD56bright NK cells generated after 30 days of culture with FLT3-L plus IL-15 did not show a considerable apoptosis, nevertheless only a subset of these cells expressed granzyme-B, perforin, LFA-1, and CD94-CD159a heterodimer, indicating a functional immaturity. Interestingly, further 15 days of culture with IL-21 plus IL-15 did not induce the generation of CD56dim cells from the CD56bright subset and actually inhibited IL-15-induced maturation/activation of this latter subset. In fact, IL-15 alone upregulated granzyme-B, TRAIL, Fas ligand, CD94-CD159a, LFA-1, CD16, KIRs, and TRAIL-R2 on CD56bright NK cells. Our results suggest that during differentiation CD56bright NK cells, similarly to mature activated NK cells, become highly cytotoxic and are relatively resistant to apoptosis induced by TNF family members. (C) 2012 International Society for Advancement of Cytometry.
引用
收藏
页码:294 / 302
页数:9
相关论文
共 50 条
  • [31] Selective Depletion of CD56dim NK Cell Subsets and Maintenance of CD56bright NK Cells in Treatment-Naive HIV-1-Seropositive Individuals
    Raquel Tarazona
    Javier G. Casado
    Olga Delarosa
    Julian Torre-Cisneros
    Jose L. Villanueva
    Berta Sanchez
    Maria D. Galiani
    Rafael Gonzalez
    Rafael Solana
    Jose Pena
    Journal of Clinical Immunology, 2002, 22 : 176 - 183
  • [32] Human intrahepatic CD56bright NK cells display a tissue-resident transcriptional profile and enhanced ability to kill allogenic CD8+T cells
    Jameson, Grainne
    Harmon, Cathal
    Santiago, Rhyla Mae
    Gallagher, Tom
    Lynch, Lydia
    Robinson, Mark W.
    O'Farrelly, Cliona
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 78 - 78
  • [33] Caspase-8L expression protects CD34+hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis
    Mohr, A
    Zwacka, RM
    Jarmy, G
    Büneker, C
    Schrezenmeier, H
    Döhner, K
    Beltinger, C
    Wiesneth, M
    Debatin, KM
    Stahnke, K
    ONCOGENE, 2005, 24 (14) : 2421 - 2429
  • [34] Expansion of cytotoxic CD56bright natural killer cells during T-cell deficiency after allogeneic hematopoietic stem cell transplantation
    Lugthart, Gertjan
    Goedhart, Marieke
    van Leeuwen, Merle M.
    Melsen, Janine E.
    Zijde, Cornelia M. Jol-van der
    Vervat, Carly
    van Ostaijen-ten Dam, Monique M.
    Jansen-Hoogendijk, Anja M.
    van Tol, Maarten J. D.
    Lankester, Arjan C.
    Schilham, Marco W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (05) : 1466 - +
  • [35] A method for the generation of large numbers of dendritic cells from CD34+hematopoietic stem cells from cord blood
    Bedke, Nicole
    Swindle, Emily J.
    Molnar, Camelia
    Holt, Patrick G.
    Strickland, Deborah H.
    Roberts, Graham C.
    Morris, Ruth
    Holgate, Stephen T.
    Davies, Donna E.
    Blume, Cornelia
    JOURNAL OF IMMUNOLOGICAL METHODS, 2020, 477
  • [36] An in vitro platform supports generation of human innate lymphoid cells from CD34+ hematopoietic progenitors that recapitulate ex vivo identity
    Hernandez, Daniela Carolina
    Juelke, Kerstin
    Mueller, Nils Christian
    Durek, Pawel
    Ugursu, Bilge
    Mashreghi, Mir-Farzin
    Rueckert, Timo
    Romagnani, Chiara
    IMMUNITY, 2021, 54 (10) : 2417 - +
  • [37] The Impact of Growth Hormone Therapy on the Apoptosis Assessment in CD34+Hematopoietic Cells from Children with Growth Hormone Deficiency
    Kawa, Milosz Piotr
    Stecewicz, Iwona
    Piecyk, Katarzyna
    Paczkowska, Edyta
    Roginska, Dorota
    Sobus, Anna
    Luczkowska, Karolina
    Pius-Sadowska, Ewa
    Gawrych, Elzbieta
    Petriczko, Elzbieta
    Walczak, Mieczyslaw
    Machalinski, Boguslaw
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (01)
  • [38] Hobit expression by a subset of human liver-resident CD56bright Natural Killer cells
    Lunemann, Sebastian
    Martrus, Gloria
    Goebels, Hanna
    Kautz, Tobias
    Langeneckert, Annika
    Salzberger, Wilhelm
    Koch, Martina
    Bunders, Madeleine J.
    Nashan, Bjoern
    van Gisbergen, Klaas P. J. M.
    Altfeld, Marcus
    SCIENTIFIC REPORTS, 2017, 7
  • [39] Abnormalities of quantities and functions of CD56bright natural killer cells in non-severe aplastic Anemia
    Li, Yang
    Ding, Shaoxue
    Liu, Chunyan
    Chen, Tong
    Liu, Hui
    Li, Lijuan
    Shao, Zonghong
    Fu, Rong
    HEMATOLOGY, 2019, 24 (01) : 405 - 412
  • [40] CAR-NK cells derived from cord blood originate mainly from CD56-CD7+CD34-HLA-DR-Lin- NK progenitor cells
    Wibowo, Tansri
    Kogue, Yosuke
    Ikeda, Shunya
    Yaga, Moto
    Tachikawa, Mana
    Suga, Makiko
    Kida, Shuhei
    Shibata, Kumi
    Tsutsumi, Kazuhito
    Murakami, Hiraku
    Ueda, Yasutaka
    Kato, Hisashi
    Fukushima, Kentaro
    Fujita, Jiro
    Ueda, Tomoaki
    Kusakabe, Shinsuke
    Hino, Akihisa
    Ichii, Michiko
    Imai, Chihaya
    Okuzaki, Daisuke
    Kumanogoh, Atsushi
    Hosen, Naoki
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (04)